Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
6,820,799
-
Share change
-
+1,624,408
-
Total reported value
-
$90,031,703
-
Put/Call ratio
-
22%
-
Price per share
-
$13.20
-
Number of holders
-
63
-
Value change
-
+$24,023,999
-
Number of buys
-
43
-
Number of sells
-
16
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q4 2022
As of 31 Dec 2022,
PDS Biotechnology Corp - Common (PDSB) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,820,799 shares.
The largest 10 holders included
VANGUARD GROUP INC, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, LPL Financial LLC, D. E. Shaw & Co., Inc., EAM Investors, LLC, INSPIRION WEALTH ADVISORS, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.